Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) |
Common Stock [Member]
ELOC Agreement [Member]
Commitment Shares [Member]
|
Common Stock [Member]
ELOC Agreement [Member]
|
Common Stock [Member]
GSS Agreement [Member]
|
Common Stock [Member]
Conversion of Notes into Common Stock [Member]
|
Common Stock [Member]
Conversion of Preferred Stock and Accrued Dividends Into Common Stock [Member]
|
Common Stock [Member]
Conversion of Preferred Stock to Common Stock [Member]
|
Common Stock [Member]
BB Botanicals [Member]
|
Common Stock [Member] |
Preferred Stock [Member]
GSS Agreement [Member]
|
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
|
Preferred Stock [Member]
Conversion of Notes into Common Stock [Member]
|
Preferred Stock [Member]
Conversion of Preferred Stock and Accrued Dividends Into Common Stock [Member]
|
Preferred Stock [Member]
Conversion of Preferred Stock to Common Stock [Member]
|
Preferred Stock [Member]
BB Botanicals [Member]
|
Preferred Stock [Member] |
AOCI Attributable to Parent [Member]
ELOC Agreement [Member]
Commitment Shares [Member]
|
AOCI Attributable to Parent [Member]
ELOC Agreement [Member]
|
AOCI Attributable to Parent [Member]
GSS Agreement [Member]
|
AOCI Attributable to Parent [Member]
Series B Convertible Preferred Stock [Member]
|
AOCI Attributable to Parent [Member]
Conversion of Notes into Common Stock [Member]
|
AOCI Attributable to Parent [Member]
Conversion of Preferred Stock and Accrued Dividends Into Common Stock [Member]
|
AOCI Attributable to Parent [Member]
Conversion of Preferred Stock to Common Stock [Member]
|
AOCI Attributable to Parent [Member]
BB Botanicals [Member]
|
AOCI Attributable to Parent [Member] |
Additional Paid-in Capital [Member]
ELOC Agreement [Member]
Commitment Shares [Member]
|
Additional Paid-in Capital [Member]
ELOC Agreement [Member]
|
Additional Paid-in Capital [Member]
GSS Agreement [Member]
|
Additional Paid-in Capital [Member]
Series B Convertible Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Conversion of Notes into Common Stock [Member]
|
Additional Paid-in Capital [Member]
Conversion of Preferred Stock and Accrued Dividends Into Common Stock [Member]
|
Additional Paid-in Capital [Member]
Conversion of Preferred Stock to Common Stock [Member]
|
Additional Paid-in Capital [Member]
BB Botanicals [Member]
|
Additional Paid-in Capital [Member] |
Retained Earnings [Member]
ELOC Agreement [Member]
Commitment Shares [Member]
|
Retained Earnings [Member]
ELOC Agreement [Member]
|
Retained Earnings [Member]
GSS Agreement [Member]
|
Retained Earnings [Member]
Series B Convertible Preferred Stock [Member]
|
Retained Earnings [Member]
Conversion of Notes into Common Stock [Member]
|
Retained Earnings [Member]
Conversion of Preferred Stock and Accrued Dividends Into Common Stock [Member]
|
Retained Earnings [Member]
Conversion of Preferred Stock to Common Stock [Member]
|
Retained Earnings [Member]
BB Botanicals [Member]
|
Retained Earnings [Member] |
ELOC Agreement [Member]
Commitment Shares [Member]
|
ELOC Agreement [Member] |
GSS Agreement [Member] |
Series B Convertible Preferred Stock [Member] |
Conversion of Notes into Common Stock [Member] |
Conversion of Preferred Stock and Accrued Dividends Into Common Stock [Member] |
Conversion of Preferred Stock to Common Stock [Member] |
BB Botanicals [Member] |
Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance (in shares) at Sep. 30, 2024 | 492,383 | 5,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at Sep. 30, 2024 | $ 492 | $ 5,000 | $ (7,189) | $ 184,033,012 | $ (182,067,898) | $ 1,963,417 | |||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock (in shares) | 21,875 | 1,500 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock | $ 22 | $ 2 | $ 0 | $ 0 | 0 | $ 82,228 | $ 0 | 0 | $ 82,250 | $ 0 | |||||||||||||||||||||||||||||||||||||||||
| Issuance of stock | (2) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of accrued preferred dividends to preferred stock (in shares) | 8,125,000 | 6,672,652 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock conversion | $ 8,125 | $ 0 | $ (3,125) | $ 6,672,652 | $ 6,672,652 | ||||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock conversion (in shares) | (5,000,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock conversion | $ (5,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred dividend | 0 | 0 | 0 | 0 | (2,334,502) | $ (2,334,501) | |||||||||||||||||||||||||||||||||||||||||||||
| Net Loss | $ 0 | $ 0 | 0 | 0 | (1,360,934) | (1,360,934) | |||||||||||||||||||||||||||||||||||||||||||||
| Balance (in shares) at Jun. 30, 2025 | 8,908,444 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at Jun. 30, 2025 | $ 8,908 | $ 0 | 0 | 185,192,277 | (179,090,682) | 6,110,503 | |||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock | (2) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuance of restricted stock for share based compensation | 0 | 0 | 0 | 3,693 | 0 | 3,693 | |||||||||||||||||||||||||||||||||||||||||||||
| Change in fair value of debt related to credit risk | $ 0 | $ 0 | 7,189 | 0 | 0 | $ 7,189 | |||||||||||||||||||||||||||||||||||||||||||||
| Issuance of Common Stock, Convertible Notes (in shares) | 267,597 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Issuance of Common Stock, Convertible Notes | $ 267 | $ 0 | $ 0 | $ 1,076,470 | $ 0 | $ 1,076,737 | |||||||||||||||||||||||||||||||||||||||||||||
| Conversion of Stock, Shares Issued (in shares) | 8,125,000 | 6,672,652 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of preferred stock and accrued dividends to common stock | $ 8,125 | $ 0 | $ (3,125) | $ 6,672,652 | $ 6,672,652 | ||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of preferred stock and accrued dividends to common stock (in shares) | (5,000,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of preferred stock and accrued dividends to common stock | $ (5,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued for fractional share in reverse stock split (in shares) | 89 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance (in shares) at Sep. 30, 2025 | 8,917,054 | 1,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at Sep. 30, 2025 | $ 8,917 | $ 1,700 | 0 | 186,650,640 | (179,435,150) | $ 7,226,107 | |||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock (in shares) | 40,000 | 100,000 | 527,976 | 1,000,000 | 40,000 | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock | $ 40 | $ 100 | $ 528 | $ 1,000 | $ 0 | $ 0 | 0 | $ 61,890 | $ 2,023,692 | 361,581 | $ 0 | $ 0 | 0 | $ 0 | $ 61,990 | $ 2,024,692 | $ 362,109 | ||||||||||||||||||||||||||||||||||
| Issuance of stock | $ (40) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of accrued preferred dividends to preferred stock (in shares) | 1,108,790 | 1,108,790 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock conversion | $ 1,109 | $ 0 | $ 0 | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock conversion (in shares) | (1,108,790) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred stock conversion | $ (1,109) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| BB Botanicals Asset Acquisition (in shares) | 425,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
| BB Botanicals Asset Acquisition | $ 425 | $ 0 | $ 0 | $ 936,567 | $ 0 | $ 936,992 | |||||||||||||||||||||||||||||||||||||||||||||
| Preferred dividend declared, not paid | 0 | 0 | 0 | 0 | (71,031) | $ (71,031) | |||||||||||||||||||||||||||||||||||||||||||||
| Preferred dividend | 0 | 0 | 0 | 0 | (120,276) | (120,276) | |||||||||||||||||||||||||||||||||||||||||||||
| Net Loss | $ 0 | $ 0 | 0 | 0 | (2,208,315) | (2,208,315) | |||||||||||||||||||||||||||||||||||||||||||||
| Balance (in shares) at Jun. 30, 2026 | 11,118,820 | 1,591,210 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at Jun. 30, 2026 | $ 11,119 | $ 1,591 | $ 0 | $ 190,034,330 | $ (181,834,770) | $ 8,212,270 | |||||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock | $ (40) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of Stock, Shares Issued (in shares) | 1,108,790 | 1,108,790 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of preferred stock and accrued dividends to common stock | $ 1,109 | $ 0 | $ 0 | $ 0 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of preferred stock and accrued dividends to common stock (in shares) | (1,108,790) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of preferred stock and accrued dividends to common stock | $ (1,109) |